EH
GILD icon

Equitable Holdings’s Gilead Sciences GILD Stock Holding History

Equitable Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
95,179
-6,187
-6% -$815K 0.07% 253
2026
Q1 		$12.6M Buy
101,366
+6,607
+7% +$925K 0.08% 241
2025
Q4 		$11.6M Buy
94,759
+4,006
+4% +$487K 0.08% 217
2025
Q3 		$10.1M Sell
90,753
-2,174
-2% -$247K 0.07% 227
2025
Q2 		$10.3M Buy
92,927
+4,415
+5% +$470K 0.08% 198
2025
Q1 		$9.92M Buy
88,512
+2,728
+3% +$281K 0.09% 187
2024
Q4 		$7.92M Sell
85,784
-683
-0.8% -$61.5K 0.08% 211
2024
Q3 		$7.25M Buy
86,467
+22,560
+35% +$1.72M 0.07% 216
2024
Q2 		$4.38M Buy
63,907
+1,427
+2% +$95.2K 0.05% 288
2024
Q1 		$4.58M Buy
62,480
+405
+0.7% +$31.1K 0.05% 258
2023
Q4 		$5.03M Buy
62,075
+518
+0.8% +$40.3K 0.06% 225
2023
Q3 		$4.61M Buy
61,557
+2,090
+4% +$161K 0.07% 211
2023
Q2 		$4.58M Buy
59,467
+4,024
+7% +$321K 0.07% 204
2023
Q1 		$4.6M Buy
55,443
+6,656
+14% +$551K 0.07% 186
2022
Q4 		$4.19M Buy
48,787
+763
+2% +$60.4K 0.07% 178
2022
Q3 		$2.96M Sell
48,024
-204
-0.4% -$12.9K 0.06% 212
2022
Q2 		$2.98M Buy
48,228
+520
+1% +$32.2K 0.06% 207
2022
Q1 		$2.84M Buy
47,708
+6,864
+17% +$439K 0.05% 227
2021
Q4 		$2.97M Sell
40,844
-409
-1% -$28.2K 0.05% 223
2021
Q3 		$2.88M Buy
41,253
+156
+0.4% +$11K 0.05% 215
2021
Q2 		$2.83M Buy
41,097
+599
+1% +$40K 0.05% 209
2021
Q1 		$2.62M Buy
40,498
+5,797
+17% +$374K 0.06% 200
2020
Q4 		$2.02M Sell
34,701
-1,003
-3% -$60.5K 0.05% 220
2020
Q3 		$2.26M Buy
35,704
+1,535
+4% +$106K 0.06% 188
2020
Q2 		$2.63M Sell
34,169
-1,141
-3% -$87.4K 0.08% 160
2020
Q1 		$2.64M Buy
35,310
+1,940
+6% +$134K 0.09% 133
2019
Q4 		$2.17M Buy
+33,370
New +$2.17M 0.06% 179

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Equitable Holdings's GILD Position: Q2 2026 in Review

Equitable Holdings reduced its Gilead Sciences (GILD) stake by 6.1% in Q2 2026, selling an estimated $815K and leaving 95,179 shares worth $12M. The position accounts for 0.07% of the portfolio, ranked #253.

Equitable Holdings first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.6M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Equitable Holdings held 95,179 shares of Gilead Sciences worth $12M as of Q2 2026.
  • Equitable Holdings sold 6,187 Gilead Sciences shares in Q2 2026, an estimated $815K.
  • Gilead Sciences made up 0.07% of Equitable Holdings's portfolio in Q2 2026, its #253 holding.
  • Equitable Holdings first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Equitable Holdings's Gilead Sciences position peaked at $12.6M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.